Xysmalobium undulatum
Xysmalobium undulatum · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Xysmalobium undulatum is a medicinal plant that holds significant pharmacological potential due to its diverse therapeutic activities. Researchers have investigated its use in treating complex conditions such as depression, Alzheimer's disease, and colorectal cancer. The plant's bioactive properties are largely attributed to specific chemical compounds, including Uzarin. Various parts of the plant, specifically the roots and leaves, are utilized to create medicinal preparations. These include Uzara root extract, crude aqueous extracts, and ethanolic extracts of the whole plant.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Apocynaceae
- Distribution
- Not available
- Plant Parts
- Root · Leaf
Classification
Synonyms
Xysmalobium undulatum is a plant species that is often recognized by its alternative botanical name, Asclepias undulata. This synonym reflects historical taxonomic classifications that once placed the plant within the broader Asclepias genus. Understanding these naming conventions is essential for researchers tracking the evolutionary history of the species. While modern nomenclature favors the former, the latter remains a common reference in older scientific literature. Consequently, recognizing both terms ensures clarity when studying the unique biological characteristics of this organism.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Xysmalobium undulatum is a unique botanical specimen belonging to the vast kingdom Plantae. Within this diverse realm, it is classified under the class Equisetopsida. The plant is a member of the order Gentianales, showcasing its specific evolutionary lineage. It further falls under the family Apocynaceae, a group known for its distinct floral characteristics. Finally, this species is defined by its placement within the genus Xysmalobium.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Apocynaceae |
| Genus | Xysmalobium |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Xysmalobium undulatum is a botanical species with a notable presence across the diverse landscapes of the African continent. Its distribution spans the East Tropical Africa region, where it can be found specifically within Kenya, Tanzania, and Uganda. The plant also reaches into Northeast Tropical Africa, making appearances in the terrain of Ethiopia. Furthermore, its range extends southward into the South Tropical Africa region, including parts of Angola. This widespread occurrence highlights the adaptability of the species across varying African ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Xysmalobium undulatum is a self-supporting herb that maintains a sturdy structure within its ecosystem. This plant typically reaches a maximum height of 1.79 meters, though it can be found as small as 0.5 meters. Its varied growth habit allows it to occupy different niches depending on its specific environmental conditions. Through these dimensions, the species demonstrates a flexible physical presence in the wild.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Xysmalobium undulatum is a South African medicinal plant that has demonstrated significant therapeutic potential in recent scientific evaluations. Research involving three-dimensional colorectal cancer models indicates that extracts from this species possess notable anticancer activity by reducing cell viability and glucose consumption. Beyond its oncology applications, the plant is also recognized within ethnobotanical studies for its potential role in mental health management. Specifically, it is categorized among the most studied plants for its possible antidepressant-like effects. These dual properties highlight the importance of further pharmacological investigation into the plant's diverse medicinal capabilities.
Compounds
Xysmalobium undulatum, a plant commonly known as uzara, serves as a significant source of the bioactive compound uzarin. Research indicates that uzarin is a major constituent of the plant's roots, though its concentration can vary significantly depending on the geographic location of the sample. Beyond its traditional medicinal uses in southern Africa, uzarin has shown great promise in modern pharmacology as a potential inhibitor of the SARS-CoV-2 receptor binding domain and RNA-dependent polymerase. Because of this potential, establishing precise quality control protocols is essential for ensuring the consistency and efficacy of uzarin-based treatments. Advanced analytical techniques, such as mid-infrared spectroscopy, are now being developed to provide rapid and accurate quantification of this valuable compound within the plant.
Conditions
Xysmalobium undulatum exhibits a diverse range of therapeutic potential, including the ability to treat depression through antidepressant-like activity in various in vivo models. This South African medicinal plant is also widely recognized and used as an effective remedy for treating diarrhoea. Regarding neurodegenerative conditions, leaf extracts of the plant have demonstrated the potential to treat Alzheimer's disease by significantly reducing the production of Aβ42 protein. Furthermore, molecular modelling studies have identified the compound uzarin from the plant as a potential inhibitor of the SARS-CoV-2 RNA-dependent polymerase. The plant also shows promise in fighting COVID-19 by targeting the SARS-CoV-2 receptor binding domain.
Preparations
Xysmalobium undulatum is prepared as Uzara root extract to treat non-specific diarrhea and is also processed as crude X. undulatum aqueous extract for investigating hepatotoxicity and anti-prolific effects. The plant is further utilized in the form of crude aqueous extracts to assess potential cytotoxic activity against colorectal cancer mini-tumors. Additionally, Xysmalobium undulatum is prepared as an ethanolic extract of the whole plant, which has shown high affinity to the serotonin reuptake transport protein. These various preparation methods allow for the study of the plant's diverse pharmacological and toxicological properties.
Parts used
Xysmalobium undulatum is an ethnomedicinally important plant from southern Africa that offers significant therapeutic potential. Research indicates that the root of this species is frequently utilized, with ethanolic root extracts being studied to develop quality control protocols for its major constituent, uzarin. Additionally, the leaves of the plant have demonstrated a potent ability to decrease the production of Aβ42 protein in laboratory settings. These leaf extracts, along with specific isolated cardenolides, suggest the plant may play a role in developing treatments for Alzheimer's disease. Together, these findings highlight how different parts of the plant contribute to its diverse medicinal applications.